Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > AGE AgeX Therapeutics > Detailed Quotes

AGE AgeX Therapeutics

Watchlist
0.571
-0.029-4.83%
Close 11/28 16:00 ET
0.5710.0000.00%
Post Mkt Price 11/28 19:01 ET
High
0.610
Open
0.600
Turnover
16.79K
Low
0.570
Pre Close
0.600
Volume
28.99K
Market Cap
21.65M
P/E(TTM)
Loss
52wk High
1.390
Shares
37.95M
P/E(Static)
Loss
52wk Low
0.516
Float Cap
10.39M
Bid/Ask %
55.00%
Historical High
5.950
Shs Float
18.21M
Volume Ratio
1.96
Historical Low
0.516
Dividend TTM
--
Div Yield TTM
--
P/B
-1.43
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.16%
Amplitude
6.66%
Avg Price
0.579
Lot Size
1
Float Cap
10.39M
Bid/Ask %
55.00%
Historical High
5.950
Shs Float
18.21M
Volume Ratio
1.96
Historical Low
0.516
Dividend TTM
--
P/B
-1.43
Dividend LFY
--
Turnover Ratio
0.16%
Amplitude
6.66%
Avg Price
0.579
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
AgeX Therapeutics, Inc. operates as a biotechnology company, which engages in the development and commercialization of novel therapeutics targeting human aging and degenerative diseases. Its product pipeline includes AGEX-VASC1, AGEX-BAT1, and AGEX-iTR1547. The company was founded by Michael D. West in 2017 and is headquartered in Alameda, CA.
CEO: Dr. Michael D. West, PhD
Market: AMEX
Listing Date: 11/29/2018
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist